Leviticus Cardio Ltd.
http://leviticus-cardio.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Leviticus Cardio Ltd.
The Baxter/Claris Warning Letter: Out Of Spec, Out Of Mind
US FDA's inspection found a major problem in the operations of the facility that became Baxter’s when it acquired Claris: staff were blaming the laboratory for out-of-specification test results when they should have been fixing the manufacturing process. The result: a warning letter packed with assignments for the new owners.
Slayback’s ‘Thoughtful’ Generics Play Nets $60m KKR Investment
Niche plays continue to attract deal interest, with the global investment firm KKR pumping in $60m in the complex generic and specialty products firm Slayback Pharma, headed by a former executive of India’s Dr Reddy’s Laboratories.
Slayback’s ‘Thoughtful’ Generics Play Nets $60m KKR Investment
Niche plays continue to attract deal interest, with the global investment firm KKR pumping in $60m in the complex generic and specialty products firm Slayback Pharma, headed by a former executive of India’s Dr Reddy’s Laboratories.
Baxter Injects $625m In ‘Foundational Asset’ Claris
Baxter has snapped up India’s Claris Injectables, accelerating efforts to become a global leader in generic injectables. The deal also puts the spotlight back on the significant M&A appetite in the niche injectables segment and the scarcity premiums that such assets can command.
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice